Clinical Trial Update: Fecal Microbiota Transplantation Among Adult Patients With Hematological Malignancies [NA]

View source ↗

Summary

This clinical trial update notes ongoing enrollment of adult patients with hematologic cancer to receive fecal microbiota transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases | Conditions: Malignant Hematologic Neoplasm | NA | Status: ENROLLING_BY_INVITATION